1-4 of 4
Jean François Fléjou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 580: hENT1 testing in pancreatic ductal adenocarcinoma: Are we ready yet? A comparative analysis of the murine and the rabbit antibodies

Jerome Cros, Raphael Marechal, Jean Baptiste Bachet, Pierre Laurent-Puig, Jean Francois Flejou, Pieter Demetter, Magali Svrcek
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 580.
https://doi.org/10.1158/1538-7445.AM2015-580
Published: 01 August 2015
View article titled, Abstract 580: hENT1 testing in pancreatic ductal adenocarcinoma: Are we ready yet? A comparative analysis of the murine and the rabbit antibodies
Journal Articles

KRAS mutations in colorectal cancer is a predictive factor of response and progression free survival in patients treated with Cetuximab.

Astrid Lievre, Jean-Baptiste Bachet, Marc Ychou, Olivier Bouche, Denis Pezet, Valerie Boige, Bruno Landi, Christophe Louvet, Jean-Francois Emile, Frederic Bibeau, Marie-Danielle Diebold, Gorana Tomasic, Jean-Francois Cote, Jean-Francois Flejou, Philippe Rougier, Frederic Penault-Llorca, Pierre Laurent-Puig
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5671.
Published: 01 May 2007
View article titled, KRAS mutations in colorectal cancer is a predictive factor of response and progression free survival in patients treated with Cetuximab.
Journal Articles

Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype

Valérie Boige, Pierre Laurent-Puig, Pierre Fouchet, Jean François Fléjou, Geneviève Monges, Pierre Bedossa, Paulette Bioulac-Sage, Frédérique Capron, Anette Schmitz, Sylviane Olschwang, Gilles Thomas
Journal: Cancer Research
Cancer Res (1997) 57 (10): 1986–1990.
Published: 01 May 1997
View article titled, Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype
Open the PDF for Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype in another window
Journal Articles

PML Nuclear Bodies Are General Targets for Inflammation and Cell Proliferation

Benoît Terris, Véronique Baldin, Sylvie Dubois, Claude Degott, Jean-François Flejou, Dominique Hénin, Anne Dejean
Journal: Cancer Research
Cancer Res (1995) 55 (7): 1590–1597.
Published: 01 April 1995
View article titled, PML Nuclear Bodies Are General Targets for Inflammation and Cell Proliferation
Open the PDF for PML Nuclear Bodies Are General Targets for Inflammation and Cell Proliferation in another window